Significant differences were not found between these two groups in terms of homozygous deletions and amplifications, although MDM2/CDK4 amplifications were numerically more frequent in adenosarcomas (32% vs 0, Fisher's exact tests, P = 0.058, Fig. S3H). Here, CDK4 is linked to adenosarcoma.